Overview
- Mexico’s Health Ministry said INER identified the country’s first A(H3N2) subclade K case, and the patient recovered after outpatient antiviral treatment.
- Authorities described the subtype’s clinical picture as similar to seasonal flu, advised no public alarm, and noted SINAVE is maintaining active monitoring.
- WHO/PAHO reports rapid growth of the subclade across Europe and Asia with increasing detection in the United States and Canada, with UK services under strain.
- Peru classified national risk as low to moderate, activated surveillance for potential importations during year‑end travel, and affirmed sufficient vaccine supply for priority groups.
- Health agencies stress vaccination for older adults, young children, pregnant people, health workers and those with comorbidities, adding that current vaccines still reduce severe disease and early antiviral care is recommended.